Home / I.V. Therapy / Infusion Sets / Infusion Ports / Safety Infusion Set / Safety Infusion Set PowerLoc®2672210
Picture of Safety Infusion Set PowerLoc®2672210

Safety Infusion Set PowerLoc®2672210

Safety-Infusion-Set-PowerLoc®2672210

SKU #

#987717

MPN #

2672210

Brand

Bard

Stock

In Stock

Quantity

100

Features

PORT ACCESS KIT, POWERLOK SFTYW/Y-SITE 22GX1" (5/CS)

$96.60 USD

Attribute Name Attribute Value
McKesson # 987717
Manufacturer # 2672210
Brand PowerLoc®
Manufacturer Bard
Application Safety Infusion Set
Specifications 22 Gauge, 1 Inch
UNSPSC Code 42142533

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • With Y-Site
  • Designed to standardize port access procedures. Provides the convenience of necessary kit components in a common package. Kit components are organized to facilitate sterile "best practices" for port access related procedures. Assists clinicians in complying with guidelines for sterile port access outlined by nursing societies and the CDC
  • Educate and assist in sterile port access technique
  • Convenient documentation and tracking of port access procedure
  • Procedural checklist for simplified protocol documentation
  • An estimated 3-6% of ports placed will develop a port-related infection, impacting a cancer patient’s already challenging treatment.1, 2, 3, 4, 5 Port-related infections may be due to the initial access or in-dwell of an infusion set in the patient’s port